Form 4 for OKUR OnKure Therapeutics, Inc.
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001209191-22-061032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-13 | 2022-08-12 | OKUR | Dorenbaum Alejandro | Chief Medical Off | G - Gift | $0.00 | -22.3K | 30.0K | -43% | $0 |
| D | 2022-12-13 | 2022-12-09 | OKUR | Dorenbaum Alejandro | Chief Medical Off | A - Grant | $0.00 | +125.0K | 125.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-12 | G | D | 22,348 | $0.00 | 30,000 | D | — | — | |
| 2 | Derivative | Stock option (right to buy) | 2022-12-09 | A | A | 125,000 | $0.00 | 125,000 | D | $1.80 · — to 2032-12-08 | 125,000 Common Stock | (F1) The shares vest in a series of 16 successive equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date. |